Thomas Lycan

1.0k citations

69 papers · 691 indexed · h-index 15

Impact in

Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
Otorhinolaryngology top 10%
- Head and Neck Cancer Studies

Papers in ⓘ

Oncology 45
- Cancer Immunotherapy and Biomarkers 20
- Lung Cancer Research Studies 15
Pulmonary and Respiratory Medicine 32
- Lung Cancer Treatments and Mutations 16
- Brain Metastases and Treatment 13
- Lung Cancer Diagnosis and Treatment 7

Co-authors: Jimmy Ruiz (25 shared papers)W. Jeffrey Petty (21 shared papers)Tamjeed Ahmed (14 shared papers)Ümit Topaloĝlu (12 shared papers)Michael D. Chan (15 shared papers)Lisa Davis (2 shared papers)Lawrence J. Cheskin (2 shared papers)Michael Farris (12 shared papers)
Journals: International Journal of Radiation Oncology*Biology*Physics (7 papers)Journal of Clinical Oncology (7 papers)Cancers (5 papers)Journal of Thoracic Oncology (3 papers)JCO Clinical Cancer Informatics (2 papers)
Partner nations: United States

In The Last Decade

Thomas Lycan

59 papers receiving 673 citations

Peers

Countries citing papers authored by Thomas Lycan

Since Specialization

Citations

This map shows the geographic impact of Thomas Lycan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Lycan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Lycan more than expected).

Fields of papers citing papers by Thomas Lycan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Lycan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Lycan. The network helps show where Thomas Lycan may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas Lycan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Lycan Line = papers co-authored together Thomas Lycan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Nicotine promotes brain metastasis by polarizing microglia and suppressing innate immune function The Journal of Experimental Medicine ·Shih-Ying Wu, Fei Xing, Sambad Sharma, Kerui Wu, Abhishek Tyagi, Yin Liu, Dan Zhao, Ravindra Pramod Deshpande, Yusuke Shiozawa, Tamjeed Ahmed, Wei Zhang, Michael D. Chan, Jimmy Ruiz, Thomas Lycan, Andrew Dothard, Kounosuke Watabe	2020	77
2	Efficacy of Meal Replacements Versus a Standard Food-Based Diet for Weight Loss in Type 2 Diabetes A Controlled Clinical Trial The Diabetes Educator ·Lawrence J. Cheskin, A Mitchell, Ami D. Jhaveri, Andrea H. Mitola, Lisa Davis, Rebecca Lewis, Mary A. Yep, Thomas Lycan	2008	77
3	A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung Carcinoma PLoS ONE ·Thomas Lycan, Timothy S. Pardee, W. Jeffrey Petty, Marcelo Bonomi, Angela Alistar, Zanetta S. Lamar, Scott Isom, Michael D. Chan, Antonius A. Miller, Jimmy Ruiz	2016	49
4	SMARCA4 mutations in KRAS ‐mutant lung adenocarcinoma: a multi‐cohort analysis Molecular Oncology ·Liang Liu, Tamjeed Ahmed, W. Jeffrey Petty, Stefan C. Grant, Jimmy Ruiz, Thomas Lycan, Ümit Topaloĝlu, Ping‐Chieh Chou, Lance D. Miller, Gregory A. Hawkins, Martha A. Alexander‐Miller, Stacey S. O’Neill, Bayard L. Powell, Ralph B. D’Agostino, Reginald F. Munden, Boris Pasche, Wei Zhang	2020	46
5	Severe neurologic complications of immune checkpoint inhibitors: a single-center review Journal of Neurology ·Sarah Mancone, Thomas Lycan, Tamjeed Ahmed, Ümit Topaloĝlu, Andrew Dothard, W. Jeffrey Petty, Roy E. Strowd	2018	44
6	Patient-Reported Outcomes From Patients Receiving Immunotherapy or Chemoimmunotherapy for Metastatic Non–Small-Cell Lung Cancer in Clinical Practice Clinical Lung Cancer ·Laurie E. McLouth, Thomas Lycan, Beverly J. Levine, Jennifer Gabbard, Jimmy Ruiz, Michael Farris, Stefan C. Grant, Nicholas M. Pajewski, Kathryn E. Weaver, W. Jeffrey Petty	2019	34
7	Lack of energy compensation over 4 days when white button mushrooms are substituted for beef Appetite ·Lawrence J. Cheskin, Lisa Davis, Leah M. Lipsky, Andrea H. Mitola, Thomas Lycan, Vanessa Mitchell, Brooke Mickle, Emily Adkins	2007	30
8	Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non–Small-Cell Lung Cancer Clinical Lung Cancer ·Tamjeed Ahmed, Thomas Lycan, Andy Dothard, Paul Ehrlichman, Jimmy Ruiz, Michael Farris, Ümit Topaloĝlu, Beverly J. Levine, Stefan C. Grant, Heidi D. Klepin, W. Jeffrey Petty	2020	27
9	Local control outcomes for combination of stereotactic radiosurgery and immunotherapy for non-small cell lung cancer brain metastases Journal of Neuro-Oncology ·Mohammed Abdulhaleem, Hannah E. Johnston, Ralph B. D’Agostino, C.M. Lanier, M.C. LeCompte, Christina K. Cramer, Jimmy Ruiz, Thomas Lycan, Hui‐Wen Lo, Kuonosuke Watabe, Stacey S. O’Neill, Christopher T. Whitlow, Jaclyn J. White, Stephen B. Tatter, Adrian W. Laxton, Jing Su, Michael D. Chan	2022	26
10	Limited-Stage Small Cell Lung Cancer: Is Prophylactic Cranial Irradiation Necessary? Practical Radiation Oncology ·Michael Farris, W.H. Wheless, Ryan T. Hughes, M. Soike, Adrianna Masters, Corbin A. Helis, Michael D. Chan, Christina K. Cramer, Jimmy Ruiz, Thomas Lycan, W. Jeffrey Petty, Tamjeed Ahmed, C.M. Leyrer, A. William Blackstock	2019	26
11	Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma Cancers ·Kimberly Burcher, Jeffrey Lantz, Elena Gavrila, Arianne Abreu, Jack T. Burcher, Andrew T. Faucheux, Amy Xie, Clayton Jackson, Alexander H. Song, Ryan T. Hughes, Thomas Lycan, Paul M. Bunch, Cristina M. Furdui, Ümit Topaloĝlu, Ralph B. D’Agostino, Wei Zhang, Mercedes Porosnicu	2021	25
12	Human papillomavirus-associated squamous cell carcinoma of the larynx or hypopharynx: Clinical outcomes and implications for laryngeal preservation Oral Oncology ·Ryan T. Hughes, William J. Beuerlein, Stacey S. O’Neill, Mercedes Porosnicu, Thomas Lycan, Joshua D. Waltonen, Bart Frizzell, Kathryn M. Greven	2019	23
13	Unmet Care Needs and Financial Hardship in Patients With Metastatic Non–Small-Cell Lung Cancer on Immunotherapy or Chemoimmunotherapy in Clinical Practice JCO Oncology Practice ·Laurie E. McLouth, Chandylen L. Nightingale, Beverly J. Levine, Jessica L. Burris, Jean A. McDougall, Thomas Lycan, Jennifer Gabbard, Jimmy Ruiz, Michael Farris, A. William Blackstock, Stefan C. Grant, W. Jeffrey Petty, Kathryn E. Weaver	2021	22
14	Prevalence of DNA Repair Gene Mutations in Blood and Tumor Tissue and Impact on Prognosis and Treatment in HNSCC Cancers ·Kimberly Burcher, Andrew T. Faucheux, Jeffrey Lantz, Harper L. Wilson, Arianne Abreu, Kiarash Salafian, Manisha J. Patel, Alexander H. Song, Robin M. Petro, Thomas Lycan, Cristina M. Furdui, Ümit Topaloĝlu, Ralph B. D’Agostino, Wei Zhang, Mercedes Porosnicu	2021	17
15	Neuromuscular ultrasound for taxane peripheral neuropathy in breast cancer Muscle & Nerve ·Thomas Lycan, Fang‐Chi Hsu, Christine Ahn, Alexandra Thomas, Francis O. Walker, Omar P. Sangüeza, Yusuke Shiozawa, Sun Hee Park, Christopher M. Peters, E. Alfonso Romero‐Sandoval, Susan A. Melin, Steven Sorscher, Katherine Ansley, Glenn J. Lesser, Michael S. Cartwright, Roy E. Strowd	2020	16
16	c-Met Mediated Cytokine Network Promotes Brain Metastasis of Breast Cancer by Remodeling Neutrophil Activities Cancers ·Yin Liu, Margaret Smith, Yuezhu Wang, Ralph B. D’Agostino, Jimmy Ruiz, Thomas Lycan, Gregory L. Kucera, Lance D. Miller, Wencheng Li, Michael D. Chan, Michael Farris, Jing Su, Qianqian Song, Dawen Zhao, Arvind Chandrasekaran, Fei Xing	2023	13
17	Sociodemographic predictors of patients with brain metastases treated with stereotactic radiosurgery Oncotarget ·Natalie K. Alphonse‐Sullivan, Glen B. Taksler, Thomas Lycan, Kathryn E. Weaver, E. McTyre, R.F. Shenker, B.R. Page, Scott Isom, Adam G. Johnson, Michael T. Munley, Adrian W. Laxton, Stephen B. Tatter, Kounosuke Watabe, Michael D. Chan, Jimmy Ruiz	2017	12
18	A Case Report of Immune Checkpoint Inhibitor-Induced Aortitis Treated with Tocilizumab SHILAP Revista de lepidopterología ·Chance H. Bloomer, Rahul Annabathula, Vanya Aggarwal, Bharathi Upadhya, Thomas Lycan	2022	12
19	Workflow Differences Affect Data Accuracy in Oncologic EHRs: A First Step Toward Detangling the Diagnosis Data Babel JCO Clinical Cancer Informatics ·Franck Diaz‐Garelli, Roy E. Strowd, Virginia Lawson, María E. Mayorga, Brian J. Wells, Thomas Lycan, Ümit Topaloĝlu	2020	11
20	Prognostic Awareness, Palliative Care Use, and Barriers to Palliative Care in Patients Undergoing Immunotherapy or Chemo-Immunotherapy for Metastatic Lung Cancer Journal of Palliative Medicine ·Laurie E. McLouth, Jennifer Gabbard, Beverly J. Levine, Shannon L. Golden, Thomas Lycan, W. Jeffrey Petty, Kathryn E. Weaver	2023	10

About Thomas Lycan

Thomas Lycan is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Epidemiology, Molecular Biology and Otorhinolaryngology, having authored 69 papers that have together received 691 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (20 papers), Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Research Studies (15 papers), Brain Metastases and Treatment (13 papers), Head and Neck Cancer Studies (9 papers), Lung Cancer Diagnosis and Treatment (7 papers), Cancer Genomics and Diagnostics (6 papers) and Glioma Diagnosis and Treatment (5 papers). The work is most often cited by research in Oncology (317 citations), Otorhinolaryngology (42 citations), Pulmonary and Respiratory Medicine (228 citations), Pharmacy (27 citations) and Cancer Research (76 citations). Thomas Lycan has collaborated with scholars based in United States. Frequent co-authors include Jimmy Ruiz, W. Jeffrey Petty, Tamjeed Ahmed, Ümit Topaloĝlu, Michael D. Chan, Lisa Davis, Lawrence J. Cheskin, Michael Farris, Beverly J. Levine and Stefan C. Grant. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, Cancers, Journal of Thoracic Oncology and JCO Clinical Cancer Informatics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact